Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/87621
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Conference item |
Title: | The tyrosine kinase inhibitor dasatinib decreases osteoclast formation and activity in vitro |
Author: | Vandyke, K. Dewar, A.L. Davis, A.N. Fiuer, S. Hughes, T.P. To, L.B. Zannettino, A.C.W. |
Citation: | Journal of Bone and Mineral Research, 2008, vol.23, iss.Suppl. s1, pp.S260-S261 |
Publisher: | Wiley |
Issue Date: | 2008 |
ISSN: | 0884-0431 1523-4681 |
Conference Name: | 30th Annual Meeting of the American Society for Bone and Mineral Research (12 Sep 2008 - 16 Sep 2008 : Montreal, Canada) |
Statement of Responsibility: | K. Vandyke, A. L. Dewar, A. N. Davis, S. Fitter, T. P. Hughes, L. B. To, A. C. W. Zannettino |
Description: | Conference abstract SU074 |
Rights: | Copyright © 2008 ASBMR |
DOI: | 10.1002/jbmr.5650231305 |
Published version: | http://dx.doi.org/10.1002/jbmr.5650231305 |
Appears in Collections: | Aurora harvest 2 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.